James M. McGill

1.2k total citations
21 papers, 840 citations indexed

About

James M. McGill is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, James M. McGill has authored 21 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in James M. McGill's work include Pediatric Hepatobiliary Diseases and Treatments (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Hepatitis C virus research (4 papers). James M. McGill is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Hepatitis C virus research (4 papers). James M. McGill collaborates with scholars based in United States, Japan and Taiwan. James M. McGill's co-authors include Christine M. Hunt, Lynn D. Condreay, Gianfranco Alpini, Nicholas F. LaRusso, John Fitz, Srisaila Basavappa, Allen W. Mangel, John P. Middleton, A Kwiatkowski and Thorsten Schlenker and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

James M. McGill

19 papers receiving 820 citations

Peers

James M. McGill
Wasim Dar United States
Stan Bukofzer United States
Justin R. Henning United States
Min-Ju Kim South Korea
Emily Bellavance United States
Wasim Dar United States
James M. McGill
Citations per year, relative to James M. McGill James M. McGill (= 1×) peers Wasim Dar

Countries citing papers authored by James M. McGill

Since Specialization
Citations

This map shows the geographic impact of James M. McGill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. McGill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. McGill more than expected).

Fields of papers citing papers by James M. McGill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. McGill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. McGill. The network helps show where James M. McGill may publish in the future.

Co-authorship network of co-authors of James M. McGill

This figure shows the co-authorship network connecting the top 25 collaborators of James M. McGill. A scholar is included among the top collaborators of James M. McGill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. McGill. James M. McGill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xing, Aokun Chen, James M. McGill, et al.. (2025). Enhancing Patient-Trial Matching With Large Language Models: A Scoping Review of Emerging Applications and Approaches. JCO Clinical Cancer Informatics. 9(9). e2500071–e2500071.
2.
Rubin, David T., Klaus Gottlieb, Jean‐Frédéric Colombel, et al.. (2023). Development of a Novel Ulcerative Colitis Endoscopic Mayo Score Prediction Model Using Machine Learning. SHILAP Revista de lepidopterología. 2(7). 935–942. 3 indexed citations
3.
Gottlieb, Klaus, James Requa, William E. Karnes, et al.. (2020). Central Reading of Ulcerative Colitis Clinical Trial Videos Using Neural Networks. Gastroenterology. 160(3). 710–719.e2. 92 indexed citations
4.
McGill, James M., et al.. (2020). Uniting Discovery and Care: The Role of Pharmaceutical Companies in Research, Clinical Studies, and Patient Care. Journal of Investigative Dermatology. 140(3). 527–530. 3 indexed citations
5.
Wrishko, Rebecca E., et al.. (2009). Safety, Efficacy, and Pharmacokinetic Overview of Low-Dose Daily Administration of Tadalafil. The Journal of Sexual Medicine. 6(7). 2039–2048. 50 indexed citations
6.
Hellstrom, Wayne J.G., Marc Gittelman, Jonathan P. Jarow, et al.. (2007). An Evaluation of Semen Characteristics in Men 45 Years of Age or Older after Daily Dosing with Tadalafil 20mg: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, 9-Month Study. European Urology. 53(5). 1058–1065. 44 indexed citations
7.
Marumo, Ken, et al.. (2006). A Comparison of the Efficacy and Tolerability of Tadalafil 10 mg and 20 mg in Japanese Patients with Severe Erectile Dysfunction. The Journal of Sexual Medicine. 4(3). 745–752. 7 indexed citations
8.
Soon, Danny, et al.. (2004). Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection. Journal of Hepatology. 41(5). 852–858. 8 indexed citations
9.
Alpini, Gianfranco, James M. McGill, & Nicholas F. LaRusso. (2002). The pathobiology of biliary epithelia. Hepatology. 35(5). 1256–1268. 115 indexed citations
10.
Wise, Stephen D., Danny Soon, Stephen L. Lowe, et al.. (2002). Potent antiviral activity of LY582563 (MCC-478) in chronic hepatitis B infected patients. Journal of Hepatology. 36. 137–137. 1 indexed citations
11.
McGill, James M., Oscar W. Cummings, Gianfranco Alpini, et al.. (2001). Interleukin-5 inhibition of biliary cell chloride currents and bile flow. American Journal of Physiology-Gastrointestinal and Liver Physiology. 280(4). G738–G745. 11 indexed citations
12.
Kwiatkowski, A & James M. McGill. (2000). Alternative Splice Variant of γ-Calmodulin-Dependent Protein Kinase II Alters Activation by Calmodulin. Archives of Biochemistry and Biophysics. 378(2). 377–383. 12 indexed citations
13.
Hunt, Christine M., et al.. (2000). Clinical relevance of hepatitis B viral mutations. Hepatology. 31(5). 1037–1044. 281 indexed citations
14.
Kwo, Paul Y., Naga Chalasani, David W. Crabb, et al.. (2000). Alpha-interferon with ribavirin for the treatment of chronic hepatitis C in treatment naive patients. Gastroenterology. 118(4). A1459–A1459. 2 indexed citations
15.
McGill, James M. & A Kwiatkowski. (1998). Cholestatic Liver Diseases in Adults. The American Journal of Gastroenterology. 93(5). 684–691. 6 indexed citations
16.
McGill, James M., Diane M. Williams, & Christine M. Hunt. (1996). Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis. Digestive Diseases and Sciences. 41(3). 540–542. 20 indexed citations
17.
McGill, James M., et al.. (1995). Ursodeoxycholate increases cytosolic calcium concentration and activates CI− currents in a biliary cell line. Gastroenterology. 109(3). 965–972. 39 indexed citations
18.
McGill, James M., et al.. (1994). Adenosine triphosphate activates ion permeabilities in biliary epithelial cells. Gastroenterology. 107(1). 236–243. 65 indexed citations
19.
Basavappa, Srisaila, John P. Middleton, Allen W. Mangel, et al.. (1993). Cl− and K+ transport in human biliary cell lines. Gastroenterology. 104(6). 1796–1805. 54 indexed citations
20.
Yates, Allan J., et al.. (1985). The patterns of brain gangliosides of Rana catesbiana during metamorphosis and in the adult. Developmental Biology. 110(1). 255–258. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026